Cargando…
Development of OX40 agonists for canine cancer immunotherapy
Recent breakthroughs in cancer immunotherapy have provided unprecedented clinical benefits to human cancer patients. Cancer is also one of the most common causes of death in pet dogs. Thus, canine-specific immune therapies targeting similar signaling pathways can provide better treatment options for...
Autores principales: | Ruiz, Damien, Haynes, Chloe, Marable, Jonathan, Pundkar, Chetan, Nance, Rebecca L., Bedi, Deepa, Agarwal, Payal, Suryawanshi, Amol S., Mishra, Amarjit, Smith, Bruce F., Sandey, Maninder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547195/ https://www.ncbi.nlm.nih.gov/pubmed/36217551 http://dx.doi.org/10.1016/j.isci.2022.105158 |
Ejemplares similares
-
Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patients
por: Marable, Jonathan, et al.
Publicado: (2021) -
Characterization of Canine Adenovirus Type 2 Virus Infection Pattern in Canine and Human Cell Lines
por: Hogans, Madison D., et al.
Publicado: (2022) -
Dimethyl fumarate abrogates dust mite‐induced allergic asthma by altering dendritic cell function
por: Jaiswal, Anil K., et al.
Publicado: (2019) -
Short palate, lung, and nasal epithelial clone 1 (SPLUNC1) level determines steroid-resistant airway inflammation in aging
por: Jaiswal, Anil Kumar, et al.
Publicado: (2022) -
Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation
por: Jaiswal, Anil Kumar, et al.
Publicado: (2021)